World News: 14:00 GMT Thursday 6th December 2018. [Phoenix Life Sciences International via Globe Newswire via SPi World News]
DENVER, Dec. 06, 2018 (GLOBE NEWSWIRE) -- (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that it has released an online version of its Investor Relations deck with an accompanying video presentation on its website and at .
During the presentation video, Phoenix Life CEO Martin Tindall walks prospective investors through the company’s background, overall mission, business model, future plans and information on how to invest in Phoenix Life’s goal of transforming the future of global healthcare.
“We are excited to release our Investor Relations deck and video presentation on our company website to provide investors in the public markets with a clear understanding of the business of Phoenix Life, our mission and our objectives,” said Phoenix Life Sciences International CEO Martin Tindall. “With all of the momentum our company is experiencing, we have received continued interest in better understanding our company and our vision. Through this presentation, we hope to share more about Phoenix Life’s global vision of creating natural alternatives to traditional healthcare and further attract further scientific partners to join us in our mission.”
Phoenix Life plans to utilize a vertically integrated operation to produce its medical cannabis pharmaceutical products and ensure maximum efficacy. The company aims to partner with the single-payer healthcare systems of both established and emerging economies to conduct medical studies on cannabis for diabetes and establish programs for diabetes patients to receive the company's botanically derived products.
The company is also releasing videos on its website for the public to learn about its , its and . This further expands our News and Media coverage section of our website. To learn more about what the news is saying about Phoenix Life Sciences International, please visit the company’s “In the News” page at: .
To watch the Investor Relations deck presentation, please visit .
To learn more about Phoenix Life Sciences International, please visit .
These statements have not been evaluated by the FDA and therefore the products sold by Phoenix Life Sciences International are not available on U.S.
Phoenix Life Sciences International does not sell or distribute any products in the United States that are in violation of the United States Controlled Substances Act (US.CSA). This company does not grow, sell, and distribute cannabis-based products in the United States and is solely involved with the legal distribution of medical cannabis-based products within certain international markets outside of the United States.
Phone: 1.888.717.5655 or international +1.720.699.7222E-mail: email@example.com
Kathryn ReinhardtCMW MediaKathryn@cmwmedia.com619-972-3089
Globe Newswire: 14:00 GMT Thursday 6th December 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.